Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors : a cross-validated approach of ligand-based and structure-based molecular modeling studies
Angiogenesis is mediated by the vascular endothelial growth factor (VEGF) that plays a key role in the modulation of progression, invasion and metastasis, related to solid tumors and hematological malignancies. Several small-molecule VEGFR-2 inhibitors are marketed, but their usage is restricted to specific cancers due to severe toxicities. Therefore, cost-effective novel small molecule VEGFR-2 inhibitors may be an alternative to overcome these adverse effects. Here, a set of thiourea-based VEGFR-2 inhibitors were considered for a combined fragment-based QSAR technique, structure-based molecular docking followed by molecular dynamics simulation studies to acquire insights into the key structural attributes and the binding pattern of enzyme-ligand interactions. Noticeably, amine-substituted quinazoline phenyl ring and a higher number of nitrogen atoms, and the hydrazide function in the molecular structure are crucial for VEGFR-2 inhibition whereas methoxy groups are detrimental to VEGFR-2 inhibition. The MD simulation study of sorafenib and thiourea derivatives explored the significance of urea and thiourea moiety binding at VEGFR-2 active site that can be utilized further in the future to design molecules for greater binding stability and better VEGFR-2 selectivity. Therefore, such findings can be beneficial for the development of newer VEGFR-2 inhibitors for further refinement to acquire better therapeutic efficacy.Communicated by Ramaswamy H. Sarma.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Journal of biomolecular structure & dynamics - 42(2024), 2 vom: 01. Jan., Seite 1047-1063 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Banerjee, Suvankar [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 30.01.2024 Date Revised 30.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/07391102.2023.2198039 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355344181 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM355344181 | ||
003 | DE-627 | ||
005 | 20240130232004.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/07391102.2023.2198039 |2 doi | |
028 | 5 | 2 | |a pubmed24n1275.xml |
035 | |a (DE-627)NLM355344181 | ||
035 | |a (NLM)37029768 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Banerjee, Suvankar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors |b a cross-validated approach of ligand-based and structure-based molecular modeling studies |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.01.2024 | ||
500 | |a Date Revised 30.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Angiogenesis is mediated by the vascular endothelial growth factor (VEGF) that plays a key role in the modulation of progression, invasion and metastasis, related to solid tumors and hematological malignancies. Several small-molecule VEGFR-2 inhibitors are marketed, but their usage is restricted to specific cancers due to severe toxicities. Therefore, cost-effective novel small molecule VEGFR-2 inhibitors may be an alternative to overcome these adverse effects. Here, a set of thiourea-based VEGFR-2 inhibitors were considered for a combined fragment-based QSAR technique, structure-based molecular docking followed by molecular dynamics simulation studies to acquire insights into the key structural attributes and the binding pattern of enzyme-ligand interactions. Noticeably, amine-substituted quinazoline phenyl ring and a higher number of nitrogen atoms, and the hydrazide function in the molecular structure are crucial for VEGFR-2 inhibition whereas methoxy groups are detrimental to VEGFR-2 inhibition. The MD simulation study of sorafenib and thiourea derivatives explored the significance of urea and thiourea moiety binding at VEGFR-2 active site that can be utilized further in the future to design molecules for greater binding stability and better VEGFR-2 selectivity. Therefore, such findings can be beneficial for the development of newer VEGFR-2 inhibitors for further refinement to acquire better therapeutic efficacy.Communicated by Ramaswamy H. Sarma | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a QSAR | |
650 | 4 | |a VEGFR-2 | |
650 | 4 | |a cancer | |
650 | 4 | |a fragment-based drug discovery | |
650 | 4 | |a molecular dynamics simulation | |
650 | 4 | |a thiourea | |
650 | 7 | |a Vascular Endothelial Growth Factor Receptor-2 |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a Ligands |2 NLM | |
650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
650 | 7 | |a Thiourea |2 NLM | |
650 | 7 | |a GYV9AM2QAG |2 NLM | |
650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
700 | 1 | |a Kejriwal, Shristi |e verfasserin |4 aut | |
700 | 1 | |a Ghosh, Balaram |e verfasserin |4 aut | |
700 | 1 | |a Lanka, Goverdhan |e verfasserin |4 aut | |
700 | 1 | |a Jha, Tarun |e verfasserin |4 aut | |
700 | 1 | |a Adhikari, Nilanjan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of biomolecular structure & dynamics |d 1985 |g 42(2024), 2 vom: 01. Jan., Seite 1047-1063 |w (DE-627)NLM012639974 |x 1538-0254 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2024 |g number:2 |g day:01 |g month:01 |g pages:1047-1063 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/07391102.2023.2198039 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 42 |j 2024 |e 2 |b 01 |c 01 |h 1047-1063 |